HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sharfstein Suggests Requiring Supplements Registration, Testing Standards

This article was originally published in The Tan Sheet

Executive Summary

Oversight authorized by DSHEA “is not the regulatory system for dietary supplements sold to the American public,” says former FDA official Joshua Sharfstein.

You may also be interested in...



John Taylor Temporarily Replaces Sharfstein As FDA's Second-In-Command

John Taylor, counselor to FDA Commissioner Margaret Hamburg, will serve temporarily as second-in-command while Hamburg considers how to reorganize the agency's leadership following Principal Deputy Commissioner Josh Sharfstein's departure.

Suggested Supplement Registry To Root Out Spiked Products Sparks Debate

A suggestion that a dietary supplement registry could help FDA weed out spiked supplements drew fire at the Council for Responsible Nutrition's conference in Lost Pines, Texas

US Proposed OTC Hearing Aid Rule Inspired Soundly Founder To ‘Make This Process Easier’

In recent interview, CEO Blake Cadwell talked about Soundly’s business model and outlook for hearing aid marketplace after FDA's pending publication of rule aiming to make the devices more accessible. Firm since June has offered online testing and advice for customers about hearing aids best suited for their needs.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS123381

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel